Directory
>
Ananth Sridhar
Ananth Sridhar
Chief Operating Officer (Eidos Therapeutics & Calcilytix Therapeutics)
San Francisco, California, United States
Ananth Sridhar
AI Summary
Ananth Sridhar is an accomplished leader in the biotechnology sector, currently serving as the Chief Operating Officer at BridgeBio, where he oversees corporate development for Eidos Therapeutics and Calcilytix Therapeutics. With a strong foundation in chemical engineering from Stanford University and an MBA from Harvard Business School, Ananth has cultivated a diverse range of expertise, including data analysis, molecular biology, and leadership in the pharmaceutical industry. His career trajectory includes significant roles at Regeneron Pharmaceuticals and advisory positions at Nanoly Bioscience and Valis Genomics. Ananth has been recognized with multiple awards, including being named a Westchester County 30 Under 30 honoree and an Intel Science Talent Search Semifinalist. He is passionate about advancing therapeutic solutions and is actively engaged in research, having published studies in prestigious journals. Ananth's unique blend of technical knowledge and strategic insight positions him as a key player in the biotechnology landscape.
Ananth Sridhar
Work Experience
Chief Operating Officer (Eidos Therapeutics & Calcilytix Therapeutics) at
Bridgebio Services Inc.
January 2024 - Present
Senior Vice President, Corporate Development (Eidos Therapeutics & Calcilytix Therapeutics) at
Bridgebio Services Inc.
May 2022 - January 2024
Vice President, Corporate Development (Eidos Therapeutics & Calcilytix Therapeutics) at
Bridgebio Services Inc.
January 2020 - May 2022
Advisor at
Nanoly Bioscience
January 2013 - January 2020
Advisor at
VALIS
January 2018 - January 2020
Senior Director, Corporate Development (Eidos Therapeutics & Calcilytix Therapeutics) at
Bridgebio Services Inc.
August 2018 - January 2020
Senior Manager, New Products Planning at
Regeneron
December 2016 - August 2018
Executive Leadership Program at
Regeneron
September 2014 - December 2016
Business Development & Strategic Intelligence at
Regeneron Pharmaceuticals
June 2013 - August 2013
Analyst at
Health Advances
August 2010 - June 2012
Research Assistant at
Leland Stanford Junior University
October 2007 - June 2010
Process Research & Development Engineer at
Genentech Foundation
June 2009 - September 2009
Researcher Assistant at
University of Colorado Health Sciences Center
June 2007 - September 2007
Ananth Sridhar
Education
Stanford University, B.S. With Honors
Harvard Business School, Master Of Business Administration (Mba)
Frequently Asked Questions about Ananth Sridhar
What is Ananth Sridhar email address?
Ananth Sridhar's primary email address is ********@eidostx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
Where Ananth Sridhar graduated from?
Ananth Sridhar holds a degree in Chemical Engineering from Stanford University.
How can I directly contact Ananth Sridhar?
To contact Ananth Sridhar directly, you can use the email address ********@eidostx.com. Complete contact information is available upon registration with Muraena.
Who is Ananth Sridhar?
Ananth Sridhar is an accomplished leader in the biotechnology sector, currently serving as the Chief Operating Officer at BridgeBio, where he oversees corporate development for Eidos Therapeutics and Calcilytix Therapeutics. With a strong foundation in chemical engineering from Stanford University and an MBA from Harvard Business School, Ananth has cultivated a diverse range of expertise, including data analysis, molecular biology, and leadership in the pharmaceutical industry. His career trajectory includes significant roles at Regeneron Pharmaceuticals and advisory positions at Nanoly Bioscience and Valis Genomics. Ananth has been recognized with multiple awards, including being named a Westchester County 30 Under 30 honoree and an Intel Science Talent Search Semifinalist. He is passionate about advancing therapeutic solutions and is actively engaged in research, having published studies in prestigious journals. Ananth's unique blend of technical knowledge and strategic insight positions him as a key player in the biotechnology landscape.
Ananth`s contact details
********@eidostx.com
**************@regeneron.com
********@users.noreply.github.com
**************@bridgebio.com
*********@mba2014.hbs.edu